Insurer Has No Duty To Defend Pharmaceutical Company Against SEC Suit, Panel Affirms
BOSTON — The First Circuit U.S. Court of Appeals on May 23 affirmed a lower federal court’s ruling in favor of an insurer in a pharmaceutical company insured’s breach of contract...To view the full article, register now.
Already a subscriber? Click here to view full article